Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Generic Stomach Remedies Expand Their Waistline, 2001 PLMA Report Shows

This article was originally published in The Tan Sheet

Executive Summary

Private label stomach remedy sales rose 5.4% to $79.8 mil. in mass merchandise outlets in 2000, an 18.4% dollar share for the year, according to PLMA's annual "Private Label Yearbook".

You may also be interested in...



Perrigo Famotidine Approved With Six Month Exclusivity; Shipments Begin

Perrigo's private label famotidine 10 mg was approved by FDA May 31, ending a drawn out delay of the generic launch.

SB Nicorette Orange Ad Support Begins In November

SmithKline Beecham expects to introduce Nicorette Orange in drug stores, mass market outlets and supermarkets nationwide near the end of October.

Supplement GMP Warning Letters Make Modest Debut In 2010

Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC

Topics

UsernamePublicRestriction

Register

ID1131849

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel